Paclitaxel-D5 (Benzoyloxy)
| Product Name | Paclitaxel-D5 (Benzoyloxy) |
|---|---|
| Alternate Names | Paclitaxel Stable Isotopes, Stable Isotopes of Paclitaxel |
| CAT No. | CS-O-16403 |
| CAS No. | 1261254-56-1 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 858.94 g/mol |
| Mol. For. | C₄₇H₄₆D₅NO₁₄ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Paclitaxel |
| Purity | 95% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | CC(O[C@@]1([C@](C[C@@H]2O)([H])OC1)[C@@]([C@@]2(C3=O)C)([H])[C@@H]([C@@](C4(C)C)(C[C@H](OC([C@H](O)[C@H](C5=CC=CC=C5)NC(C6=CC=CC=C6)=O)=O)C(C)=C4[C@H]3OC(C)=O)O)OC(C(C([2H])=C7[2H])=C(C([2H])=C7[2H])[2H])=O)=O |
| Canonical Smiles | CC1=C2C(C(=O)C3(C(CC4C(C3C(C(C2(C)C)(CC1OC(=O)C(C(C5=CC=CC=C5)NC(=O)C6=CC=CC=C6)O)O)OC(=O)C7=CC=CC=C7)(CO4)OC(=O)C)O)C)OC(=O)C |
| InchIKey | RCINICONZNJXQF-IRNQFUICSA-N |
| Inchl | InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1/i9D,14D,15D,20D,21D |
| IUPAC | [(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] 2,3,4,5,6-pentadeuteriobenzoate |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Paclitaxel-D5 (Benzoyloxy) is a potent anticancer drug used in the treatment of ovarian, breast, lung, and other cancer types. It is a modified form of paclitaxel, a natural compound found in the bark of the Pacific yew tree. Paclitaxel-D5 (Benzoyloxy) has a similar mechanism of action to paclitaxel, inhibiting cell division by binding to microtubules and preventing their disassembly. Additionally, the deuterium substitution in Paclitaxel-D5 (Benzoyloxy) increases its stability and prolongs its half-life in the body, leading to increased efficacy and reduced toxicity compared to paclitaxel.
Paclitaxel-D5 (Benzoyloxy) is typically administered intravenously in a clinical setting. It is usually used in combination with other chemotherapy drugs for maximum efficacy. The dosage and duration of treatment depend on the type and stage of cancer, as well as the patient's overall health.
Some of the common side effects of Paclitaxel-D5 (Benzoyloxy) include low blood cell counts, fatigue, nausea, vomiting, hair loss, and neuropathy. However, these side effects are usually manageable and temporary. In rare cases, more severe adverse reactions such as allergic reactions or heart problems may occur, and patients should be closely monitored during treatment.
Overall, Paclitaxel-D5 (Benzoyloxy) is a valuable tool in the fight against cancer. Its efficacy, safety, and stability make it a preferred choice for many oncologists and patients.
Get an Instant Quote
Related Compounds
Paclitaxel-D5 (Benzoylamine) |